|
|
|||
Description:The replication and maintenance of mitochondrial DNA is dependent upon DNA polymerase gamma, the only DNA polymerase in mitochondrial matrix. DNA polymerase gamma consists of a 140-kD catalytic subunit (POLG1) and two 55-kD accessory subunits (POLG2) to form a heterotrimer holoenzyme. While mutations in POLG1 (test number 3065) have been found to be associated with PEO (test number 3300), SANDO, Parkinsonism, and Alpers syndrome, only one heterozygous mutation in POLG2 is currently reported to be associated with PEO (OMIM#610131). The in vitro study showed that in the presence of the POLG2 mutation the holoenzyme showed reduced DNA binding affinity. Thus, the disease in the reported patient is most likely due to haploinsufficiency or heterodimerization of the mutant and wild proteins. The human POLG2 gene is mapped to chromosome 17q23-q24. It contains 8 exons encoding a protein of 485 amino acids. Reasons for Referral:
Testing Methodology:The exons and flanking intronic regions of the POLG2 gene are PCR amplified and sequenced in both the forward and reverse directions. Specimen Requirements:Blood: EDTA (purple-top) tubes: Adult: 14 cc; Child: 6 cc; Infant: 2-3 cc Turnaround Time:2-4 weeks CPT Codes and Prices:
Index: 83891, 83904x16, 83898x8, 83912, 83894x2 References:1. Longley MJ, Clark S, Yu Wai Man C, Hudson G, Durham SE, Taylor RW, Nightingale S, Turnbull
DM, Copeland WC, Chinnery PF. (2006) Mutant POLG2 disrupts DNA polymerase gamma subunits
and causes progressive external ophthalmoplegia. Am J Hum Genet 78:
1026-34 Shipping InformationForms:>> Gene Sequencing Requisition or Mitochondrial Requisition - Mitochondrial Diagnostic Checklist is included Test Codes:Index: 3380 |